PremiumThe FlyNYSE notifies Enzo Biochem not in compliance with certain requirements Enzo Biochem Reports Narrowed Loss Amid Revenue Decline Enzo Biochem Appoints Jon Couchman to Board PremiumCompany AnnouncementsEnzo Biochem Executives Receive Raises and Equity Rewards Enzo Biochem Announces 2023 Annual Meeting Outcomes Enzo Biochem Shareholders Elect Directors, Reject Exec Pay PremiumThe FlyEnzo Biochem jumps over 10% after announcing asset sale to Labcorp Enzo Biochem files to sell 3.53M shares of common stock for holders Enzo Biochem reports Q3 revenue $16.1M vs. $26.2M last year